Celltrion Pharm, Inc. (068760.KQ) KOE

64,800.00

-1800(-2.70%)

Updated at November 14 03:07PM

Currency In KRW

Valuation

Market Cap2.46T
Enterprise Value2.59T
P/E Ratio86.28
PEG Ratio4.57
Price/Sales Ratio5.59
Price/Book Ratio6.85
Enterprise/Revenue5.87
Enterprise/EBITDA30.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.1

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue477.84B
Revenue/Share11,677.38
Gross Profit122.01B
EBITDA57.36B
Net Income21.97B
Diluted EPS530

Balance Sheet

Total Cash102.77B
Total Cash/Share2,364.6
Total Debt171.09B
Total Debt/Equity0.41
Current Ratio1.57
Book Value Per Share9,533.25

Price History

52-Week Change26.5
52-Week High68,700
52-Week Low44,500
Moving Average 50 Days57,124
Moving Average 200 Days52,764.75

Statistics

Average Volume155,536
Shares Outstanding43.42M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor21:20
Last Split DateDecember 27, 2024